食品科学 ›› 2021, Vol. 42 ›› Issue (7): 162-168.doi: 10.7506/spkx1002-6630-20200311-175

• 营养卫生 • 上一篇    下一篇

人参皂苷Rh2-壳聚糖纳米粒子制备及对A549细胞的抑制作用

顾倩,周静,张建梅,尚志,沈婷,杨晓君,胡卫成   

  1. (1.淮阴师范学院 江苏省区域现代农业与环境保护协同创新中心,江苏 淮安 223300;2.新疆农业大学食品科学与药学学院,新疆 乌鲁木齐 830052)
  • 出版日期:2021-04-15 发布日期:2021-05-17
  • 基金资助:
    国家自然科学基金青年科学基金项目(31700304);江苏省大学生创新创业训练计划重点项目(201810323008Z)

Preparation of Ginsenoside Rh2-Loaded Chitosan Nanoparticles and Its Cytotoxicity to A549 Cells

GU Qian, ZHOU Jing, ZHANG Jianmei, SHANG Zhi, SHEN Ting, YANG Xiaojun, HU Weicheng   

  1. (1. Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, Huaiyin Normal University, Huai’an 223300, China; 2. College of Food Science and Pharmacology, Xinjiang Agricultural University, ürümqi 830052, China)
  • Online:2021-04-15 Published:2021-05-17

摘要: 人参皂苷Rh2是一种具有抑制肿瘤生长功效的生物活性物质。本实验采用离子交联的方法制备壳聚糖纳米粒子包载人参皂苷Rh2,以解决Rh2的水溶性差、生物相容度低的问题。以纳米粒子的粒径、Zeta-电位为评价指标,对制备条件(m(壳聚糖)∶m(三聚磷酸钠)、壳聚糖分子质量以及Rh2投药量)进行探究,筛选纳米粒子最佳成球条件;通过透射电子显微镜、原子力显微镜对纳米粒子形态进行观察,采用X射线衍射考察晶型变化;最后通过体外实验探究载药纳米粒子对人非小细胞肺癌A549细胞增殖的影响以及细胞对其的摄取行为。结果表明,最优条件(m(壳聚糖)∶m(Rh2)∶m(三聚磷酸钠)为8∶1.5∶2、壳聚糖分子质量为50 kDa)下制备得到的载药纳米粒子粒径和Zeta-电位分别为(222.70±17.34)nm和(46.50±2.57)mV,载药量和包封率分别为7.89%和49.54%,载药纳米粒子分布均一、性能稳定,适用于药物递送。细胞实验结果显示载药纳米粒子能够被A549细胞摄取,较游离药物抑制A549细胞的增殖作用增强。研究表明离子交联法制备而成的壳聚糖纳米粒子是一种具有应用前景的Rh2递送载体。

关键词: 壳聚糖;纳米粒子;离子交联;人参皂苷Rh2

Abstract: In this study, chitosan nanoparticles prepared by ionic cross-linking was considered as a new vehicle for the improvement of the water solubility and biocompatiblity of ginsenoside Rh2. Based on the size and zeta potential of nanoparticles, the conditions for preparing ginsenoside Rh2-loaded nanoparticles were optimized with respect to mass ratio between chitosan and sodium tripolyphosphate, the molecular mass of chitosan and the feeding amount of Rh2. The morphology of Rh2-loaded nanoparticles was observed transmission electron microscopy and atomic force microscopy. The change of crystal types was investigated by X-ray diffraction. The anti-proliferation effect of Rh2-loaded nanoparticles on non-small cell lung cancer cells (A549) and the cellular uptake of Rh2 were studied. Under the optimal conditions as follows: mass ratio of chitosan to Rh2 to sodium tripolyphosphate 8:1.5:2 and chitosan molecular mass 50 kDa, Rh2-loaded nanoparticles whose average particle size and zeta potential were (222.70 ± 17.34) nm and (46.50 ± 2.57) mV, respectively were obtained with encapsulation and loading efficiencies of 7.89% and 49.54%, respectively. The as-prepared nanoparticles showed uniform size distribution and good stability, therefore being suitable for drug delivery. It could be uptaken by A549 cells and have higher inhibitory effect on the proliferation of A549 cells compared with free ginsenoside Rh2. Therefore, the chitosan nanoparticles prepared by ionic cross-linking are a promising carrier for the delivery of ginsenoside Rh2.

Key words: chitosan; nanoparticles; ionic cross-linking; ginsenoside Rh2

中图分类号: